Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00234819
Status:
COMPLETED
Last Update Posted:
2007-12-28
First Post:
2005-10-05
Brief Title:
Study Evaluating BazedoxifeneConjugated Estrogen Combinations in Symptoms Associated With Menopause
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
A Double-Blind Randomized Placebo-Controlled Efficacy and Safety Study of BazedoxifeneConjugated Estrogen Combinations for Treatment of Vasomotor Symptoms Associated With Menopause
Status:
COMPLETED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether bazedoxifeneconjugated estrogens combinations are effective in the treatment of moderate to severe vasomotor symptoms associated with menopause
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None